← Leaderboards
Rogelio A Mosqueda-Garcia
Vanderbilt University
$393,202
Attributed
$393,202
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$393,202 · 4
By mechanism
P01$391,426 · 1
M01$1,776 · 3
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- David Herlie Robertson$14,232,685
- John Peter Wikswo$17,124,536
- Richard M Breyer$8,994,550
- Clare McCabe$2,222,891
- Donna J Webb$5,224,583
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchSympathetic Nervous SystemSleepBeta Adrenergic ReceptorBarbituratesNervous System DisorderDisease /Disorder EtiologyPsychopharmacologyPsychological StressorAlpha Adrenergic ReceptorNeural TransmissionBrain Electrical ActivityHemodynamicsNeuropharmacologic AgentNeurophysiologyNeuroregulationNorepinephrinePositron Emission TomographyPostural HypotensionPsychomotor FunctionTransdermal Drug DeliveryGravityDrug Screening /Evaluation
Grant awards (9)
CENTRAL SYMPATHETIC DYSFUNCTION IN ORTHOSTATIC INTOLERANCE$0
M01 · FY2002 · RR
CENTRAL SYMPATHETIC DYSFUNCTION IN OTHOSTATIC INTOLERANCE$200,479
P01 · FY2001 · HL
CENTRAL SYMPATHETIC DYSFUNCTION IN ORTHOSTATIC INTOLERANCE$0
M01 · FY2001 · RR
CENTRAL SYMPATHETIC DYSFUNCTION IN ORTHOSTATIC INTOLERANCE$0
M01 · FY2001 · RR
CENTRAL SYMPATHETIC DYSFUNCTION IN ORTHOSTATIC INTOLERANCE$0
M01 · FY2001 · RR
CENTRAL SYMPATHETIC DYSFUNCTION IN OTHOSTATIC INTOLERANCE$190,947
P01 · FY2000 · HL
METABOLIC EFFECTS ON NICOTINE$592
M01 · FY2000 · RR
MECHANISMS OF ANTIARRHYTHMIC DRUG ACTION SUPPLEMENT--SIMULATED MICROGRAVITY$592
M01 · FY2000 · RR
CENTRAL SYMPATHETIC DYSFUNCTION IN ORTHOSTATIC INTOLERANCE$592
M01 · FY2000 · RR